Clinical Trial Update: Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery [Phase 1, Phase 2]

View source ↗

Summary

Updates on a Phase 1/2 clinical trial evaluating celecoxib for patients with head and neck cancer that can be removed by surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: UNKNOWN